Literature DB >> 35261844

Forearm porphyrin levels evaluated by digital imaging system are increased in patients with systemic sclerosis compared with patients in pre-clinical stage.

Kayoko Tabata1, Chikako Kaminaka2, Misaki Yasutake1, Ryo Matsumiya1, Yutaka Inaba2, Yuki Yamamoto2, Masatoshi Jinnin2, Takao Fujii1.   

Abstract

We hypothesized that changes in skin characteristics on the forearm could be useful for early diagnosis of systemic sclerosis (SSc). We used VISIA digital imaging system to investigate this possibility for the first time. Twenty-eight Japanese patients who were diagnosed with typical or very early diagnosis of SSc (VEDOSS) were enrolled in this study, and ten age- and gender-matched patients with other disorders were included as a control group. Eight skin characteristics were analyzed. Our method of evaluating forearm skin characteristics was shown to be reproducible. The scores of WRINKLES, TEXTURE, PORES, and PORPHYRINS were higher in SSc subjects with sclerotic forearm skin (SSc forearm+; 11.004, 5.116, 3.230, and 0.084, respectively) and those without (SSc forearm-: 11.915, 4.898, 2.624, 0.0616, respectively) than in the non-SSc control subjects (10.075, 4.496, 2.459, 0.0223, respectively). Also, the scores of SPOTS, TEXTURE, PORES, UV SPOTS, BROWN SPOTS, and PORPHYRINS were elevated in SSc forearm+ (3.182, 5.116, 3.230, 5.761, 6.704, 0.084, respectively) and SSc forearm- patients (2.391, 4.898, 2.624, 9.835, 5.798, 0.0616, respectively) compared with those with VEDOSS (2.362, 4.738, 2.234, 5.999, 4.898, 0.0169, respectively). We found statistical significance in the difference in score of PORPHYRINS between SSc forearm- and VEDOSS groups (p = 0.044), and between SSc forearm+ and VEDOSS groups (p = 0.012). Therefore, they can be used to differentiate VEDOSS from early or mild SSc cases, which is sometimes clinically problematic. Our study also suggests that the porphyrin research will lead to a better understanding of SSc pathogenesis. 2022, International Research and Cooperation Association for Bio & Socio - Sciences Advancement.

Entities:  

Keywords:  forearm; porphyria cutanea tarda; very early diagnosis of SSc (VEDOSS)

Year:  2022        PMID: 35261844      PMCID: PMC8898390          DOI: 10.5582/irdr.2021.01157

Source DB:  PubMed          Journal:  Intractable Rare Dis Res        ISSN: 2186-3644


  19 in total

1.  Circulating miR-29a levels in patients with scleroderma spectrum disorder.

Authors:  Yoshio Kawashita; Masatoshi Jinnin; Takamitsu Makino; Ikko Kajihara; Katunari Makino; Noritoshi Honda; Shinich Masuguchi; Satoshi Fukushima; Yuji Inoue; Hironobu Ihn
Journal:  J Dermatol Sci       Date:  2010-11-16       Impact factor: 4.563

2.  Comparison of two skin imaging analysis instruments: The VISIA® from Canfield vs the ANTERA 3D® CS from Miravex.

Authors:  F Linming; H Wei; L Anqi; C Yuanyu; X Heng; P Sushmita; L Yiming; L Li
Journal:  Skin Res Technol       Date:  2017-06-05       Impact factor: 2.365

3.  Porphyria cutanea tarda. Clinical features and laboratory findings in 40 patients.

Authors:  M E Grossman; D R Bickers; M B Poh-Fitzpatrick; V A Deleo; L C Harber
Journal:  Am J Med       Date:  1979-08       Impact factor: 4.965

4.  Micronutrient antioxidant status in patients with primary Raynaud's phenomenon and systemic sclerosis.

Authors:  A L Herrick; F Rieley; D Schofield; S Hollis; J M Braganza; M I Jayson
Journal:  J Rheumatol       Date:  1994-08       Impact factor: 4.666

5.  VISIA system: a possible tool in the cosmetic practice.

Authors:  Anne Goldsberry; C William Hanke; Katherine E Hanke
Journal:  J Drugs Dermatol       Date:  2014-11       Impact factor: 2.114

6.  2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative.

Authors:  Frank van den Hoogen; Dinesh Khanna; Jaap Fransen; Sindhu R Johnson; Murray Baron; Alan Tyndall; Marco Matucci-Cerinic; Raymond P Naden; Thomas A Medsger; Patricia E Carreira; Gabriela Riemekasten; Philip J Clements; Christopher P Denton; Oliver Distler; Yannick Allanore; Daniel E Furst; Armando Gabrielli; Maureen D Mayes; Jacob M van Laar; James R Seibold; Laszlo Czirjak; Virginia D Steen; Murat Inanc; Otylia Kowal-Bielecka; Ulf Müller-Ladner; Gabriele Valentini; Douglas J Veale; Madelon C Vonk; Ulrich A Walker; Lorinda Chung; David H Collier; Mary Ellen Csuka; Barri J Fessler; Serena Guiducci; Ariane Herrick; Vivien M Hsu; Sergio Jimenez; Bashar Kahaleh; Peter A Merkel; Stanislav Sierakowski; Richard M Silver; Robert W Simms; John Varga; Janet E Pope
Journal:  Ann Rheum Dis       Date:  2013-11       Impact factor: 19.103

7.  Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies.

Authors:  P J Clements; P A Lachenbruch; J R Seibold; B Zee; V D Steen; P Brennan; A J Silman; N Allegar; J Varga; M Massa
Journal:  J Rheumatol       Date:  1993-11       Impact factor: 4.666

8.  Serum levels of soluble carbonic anhydrase IX are decreased in patients with diffuse cutaneous systemic sclerosis compared to those with limited cutaneous systemic sclerosis.

Authors:  Katsunari Makino; Masatoshi Jinnin; Takamitsu Makino; Ikko Kajihara; Satoshi Fukushima; Yuji Inoue; Hironobu Ihn
Journal:  Biosci Trends       Date:  2014-06       Impact factor: 2.400

9.  Novel Use of Non-Invasive Devices and Microbiopsies to Assess Facial Skin Rejuvenation Following Laser Treatment.

Authors:  Mikaela Kislevitz; Karen B Lu; Christine Wamsley; John Hoopman; Jeffrey Kenkel; Yucel Akgul
Journal:  Lasers Surg Med       Date:  2020-03-15       Impact factor: 4.025

10.  Objective assessment of facial skin aging and the associated environmental factors in Japanese monozygotic twins.

Authors:  Ryoko Ichibori; Takashi Fujiwara; Tomoko Tanigawa; Shigeyuki Kanazawa; Kenta Shingaki; Kosuke Torii; Koichi Tomita; Kenji Yano; Yasuo Sakai; Ko Hosokawa
Journal:  J Cosmet Dermatol       Date:  2014-06       Impact factor: 2.696

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.